Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

39.92
-0.7500-1.84%
Post-market: 40.000.0800+0.20%19:30 EDT
Volume:4.34M
Turnover:172.54M
Market Cap:95.65B
PE:21.41
High:40.07
Open:39.58
Low:39.50
Close:40.67
52wk High:52.68
52wk Low:39.50
Shares:2.40B
Float Shares:2.16B
Volume Ratio:1.18
T/O Rate:0.20%
Dividend:2.32
Dividend Rate:5.81%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.23
PE(LYR):10.62

Loading ...

Sanofi Prices $2.7 Billion in Bonds in Three-Part Offering

MT Newswires Live
·
Apr 25

Sanofi Says Secondary Progressive Multiple Sclerosis Treatment Recommended for Approval in EU

MT Newswires Live
·
Apr 24

European Equities Traded in US as ADRs Ease in Thursday Trading

MT Newswires Live
·
Apr 23

Sector Update: Health Care Stocks Decline Premarket Thursday

MT Newswires Live
·
Apr 23

Sanofi SA reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 23

Analysts Conflicted on These Healthcare Names: Sanofi (SNY), BrightSpring Health Services, Inc. (BTSG) and Collegium Pharmaceutical (COLL)

TIPRANKS
·
Apr 23

Sanofi's Dupixent Success Masks R&D Concerns as New CEO Takes the Helm

Stock News
·
Apr 23

Sanofi Eyes First On-Body Injector Cancer Therapy As FDA Delays Decision

Benzinga_recent_news
·
Apr 22

Sanofi Says Tzield Gets US Approval to Delay Stage 3 Type 1 Diabetes Onset in Young Children

MT Newswires Live
·
Apr 22

Sanofi SA expected to post earnings of $1.03 a share - Earnings Preview

Reuters
·
Apr 21

Sanofi Says Its COVID-19 Vaccine Shows Better Tolerability Than Moderna Alternative in Phase 4 Trial

MT Newswires Live
·
Apr 20

Sanofi says COVID-19 vaccine showed better tolerability than Moderna’s

TIPRANKS
·
Apr 18

France's 2026 Market Story Could Stay Centered On Luxury, Pharma And Banks

Benzinga_recent_news
·
Apr 18

AI Drug Discovery Firm Valued at $1 Billion Following Funding Round, Attracts Investment from Pharma Giants

Deep News
·
Apr 16

Earning Preview: Sanofi SA revenue this quarter is expected to increase by 10.21%, and institutional views are bullish

Earnings Agent
·
Apr 16

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

Regeneron, Sanofi announce European Commission approval for Dupixent indication

TIPRANKS
·
Apr 13

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

GlobeNewswire
·
Apr 13

Sanofi Investors Might Have to Wait for Update on Strategy -- Market Talk

Dow Jones
·
Apr 10

Sanofi Could Get Boost From Dupixent U.S. Price -- Market Talk

Dow Jones
·
Apr 10